Avi Biopharma, Inc. (AVII)

Avi Biopharma, Inc. is related to 1 other symbol. To date we've encountered releases involving Avi Biopharma, Inc..

Last Price: 0.6101 (-0.0399) - 12/2/2008, 3:30pm

• Open: 0.68
• High: 0.68
• Low: 0.594

Avi Biopharma, Inc. Options

• Avi Biopharma, Inc. "Business Partners"
• Avi Biopharma, Inc. Press Releases
• Avi Biopharma, Inc. News
• Avi Biopharma, Inc. Contact
• Avi Biopharma, Inc. Related (via TRYNT)

Avi Biopharma, Inc. "Business Partners"

A "business partner" is defined as a third party company that has co-released at least one press release with Avi Biopharma, Inc..

^

Avi Biopharma, Inc. Press Releases

• We have not detected any press releases (via MarketWire) yet.

^

Avi Biopharma, Inc. News

• AVI BioPharma Strengthens Patent Position in Exon Skipping (Marketwire), Mon, 24 Nov 2008 13:05:00 Etc/GMT
• AVI BIOPHARMA INC Financials (EDGAR Online Financials), Tue, 18 Nov 2008 14:04:34 Etc/GMT
• AVI BioPharma Announces Third Quarter 2008 Financial Results (Marketwire), Mon, 10 Nov 2008 13:30:00 Etc/GMT
• AVI BioPharma Announces Initiation of Clinical Trial of Next Generation Drug Eluting Stent by Partner Global Therapeutics (Marketwire), Mon, 10 Nov 2008 13:00:00 Etc/GMT
• Q3 2008 AVI BioPharma Earnings Release - Time Not Supplied (CCBN), Mon, 10 Nov 2008 12:07:08 Etc/GMT
• AVI BIOPHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit (EDGAR Online), Mon, 10 Nov 2008 11:04:54 Etc/GMT
• AVI BioPharma Announces Third Quarter 2008 Financial Results Conference Call (Marketwire), Tue, 4 Nov 2008 13:10:00 Etc/GMT
• AVI BioPharma to Present at Rodman & Renshaw's Annual Global Investment Conference Nov. 11, 2008 (Marketwire), Tue, 4 Nov 2008 13:00:00 Etc/GMT
• AVI BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Regulation FD Disclosure (EDGAR Online), Fri, 31 Oct 2008 16:12:54 Etc/GMT
• AVI BioPharma to Co-Host Exon Skipping Conference for Duchenne Muscular Dystrophy (Marketwire), Tue, 14 Oct 2008 16:00:00 Etc/GMT
• AVI BioPharma's Drug for Duchenne Muscular Dystrophy Recommended for Orphan Drug Status in EU and Receiving Provisional GTAC Approval for Clinical Trial in UK (Marketwire), Tue, 14 Oct 2008 13:30:00 Etc/GMT
• AVI BioPharma to Present at the JMP and Maxim Healthcare Conferences (Marketwire), Wed, 1 Oct 2008 16:00:00 Etc/GMT
• AVI BioPharma to Present at the UBS Global Life Sciences Conference (Marketwire), Mon, 22 Sep 2008 13:30:00 Etc/GMT
• AVI BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online), Fri, 19 Sep 2008 18:34:17 Etc/GMT
• AVI BioPharma to Host Analyst & Investor Breakfast Meeting (Marketwire), Mon, 8 Sep 2008 13:30:00 Etc/GMT
• AVI BIOPHARMA INC Files SEC form 10-Q, Quarterly Report (EDGAR Online), Mon, 11 Aug 2008 20:07:19 Etc/GMT
• AVI BioPharma Announces Approval to Conduct Systemic Trial for Duchenne Muscular Dystrophy and Second Quarter 2008 Financial Results (Marketwire), Mon, 11 Aug 2008 13:00:00 Etc/GMT
• AVI BioPharma Announces Second Quarter 2008 Financial Results Conference Call (Marketwire), Thu, 7 Aug 2008 13:30:00 Etc/GMT
• AVI BioPharma to Present at BMO Healthcare Conference (Marketwire), Mon, 4 Aug 2008 13:30:00 Etc/GMT
• AVI BIOPHARMA INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (EDGAR Online), Mon, 28 Jul 2008 20:45:10 Etc/GMT

^

Avi Biopharma, Inc. Contact

• We have not detected any contact information yet.

TRYNT Related

• TRYNT did not suggest any related symbols

^

What is a Stock Cloud?

A Stock Cloud is a tag cloud like display of stock ticker symbols. The larger the ticker symbol the more frequent that company distributes press releases.